株式会社極東書店トップ > 商品一覧 > Formulating Poorly Water Soluble Drugs. Third Edition 2022
商品詳細
Formulating Poorly Water Soluble Drugs. Third Edition 2022
・ISBN 978-3-030-88721-6 paper EUR 229.99
¥61,475.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Williams III, Robert O. / Davis Jr., Daniel A. / Miller, Dave A. (eds.), |
|---|---|
| シリーズ | (AAPS Advances in the Pharmaceutical Sciences Series) |
| 出版社 | (Springer Nature Switzerland AG, SZ) |
| 出版年月 | 2023 |
| ページ数 | 693 pp. |
| 言語 | ENG |
| ニュース番号 | <A02-74658> |
解説
The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.